Mirae Asset Global ETFs Holdings
KYMR icon

Mirae Asset Global ETFs Holdings’s Kymera Therapeutics KYMR Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.69M Buy
41,126
+2,827
+7% +$243K 0.01% 886
2026
Q1 		$3.17M Sell
38,299
-2,478
-6% -$196K ﹤0.01% 985
2025
Q4 		$3.17M Buy
40,777
+13,859
+51% +$936K ﹤0.01% 962
2025
Q3 		$1.53M Sell
26,918
-693
-3% -$31.3K ﹤0.01% 1263
2025
Q2 		$1.21M Sell
27,611
-3,182
-10% -$110K ﹤0.01% 1355
2025
Q1 		$849K Buy
30,793
+1,833
+6% +$66.8K ﹤0.01% 1580
2024
Q4 		$1.16M Buy
28,960
+2,011
+7% +$90.8K ﹤0.01% 1470
2024
Q3 		$1.28M Buy
26,949
+2,379
+10% +$105K ﹤0.01% 1403
2024
Q2 		$735K Buy
+24,570
New +$851K ﹤0.01% 1622

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's KYMR Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Kymera Therapeutics (KYMR) stake by 7.4% in Q2 2026, buying an estimated $243K and bringing the position to 41,126 shares worth $4.69M. The position accounts for 0.01% of the portfolio, ranked #886.

Mirae Asset Global ETFs Holdings first reported a position in KYMR in Q2 2024 and has held it in 9 quarters since. 275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 41,126 shares of Kymera Therapeutics worth $4.69M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 2,827 Kymera Therapeutics shares in Q2 2026, an estimated $243K.
  • Kymera Therapeutics made up 0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #886 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Kymera Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.